• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
TSH receptor-adenovirus-induced Graves' hyperthyroidism is attenuated in both interferon-gamma and interleukin-4 knockout mice; implications for the Th1/Th2 paradigm.促甲状腺激素受体腺病毒诱导的格雷夫斯甲亢在干扰素-γ和白细胞介素-4基因敲除小鼠中均有所减轻;对Th1/Th2模式的启示。
Clin Exp Immunol. 2004 Dec;138(3):417-22. doi: 10.1111/j.1365-2249.2004.02641.x.
2
Schistosoma mansoni and alpha-galactosylceramide: prophylactic effect of Th1 Immune suppression in a mouse model of Graves' hyperthyroidism.曼氏血吸虫与α-半乳糖神经酰胺:Th1免疫抑制在Graves病甲亢小鼠模型中的预防作用
J Immunol. 2004 Aug 1;173(3):2167-73. doi: 10.4049/jimmunol.173.3.2167.
3
Prevention of autoantibody-mediated Graves'-like hyperthyroidism in mice with IL-4, a Th2 cytokine.用白细胞介素-4(一种Th2细胞因子)预防小鼠自身抗体介导的格雷夫斯样甲状腺功能亢进症。
J Immunol. 2003 Apr 1;170(7):3522-7. doi: 10.4049/jimmunol.170.7.3522.
4
Dendritic cells infected with adenovirus expressing the thyrotrophin receptor induce Graves' hyperthyroidism in BALB/c mice.感染表达促甲状腺激素受体的腺病毒的树突状细胞可在BALB/c小鼠中诱发格雷夫斯甲亢。
Clin Exp Immunol. 2003 Feb;131(2):234-40. doi: 10.1046/j.1365-2249.2003.02080.x.
5
Differential requirement of signal transducer and activator of transcription-4 (Stat4) and Stat6 in a thyrotropin receptor-289-adenovirus-induced model of Graves' hyperthyroidism.信号转导及转录激活因子4(Stat4)和Stat6在促甲状腺素受体289-腺病毒诱导的格雷夫斯甲亢模型中的不同需求
Endocrinology. 2006 Jan;147(1):111-9. doi: 10.1210/en.2005-1031. Epub 2005 Sep 29.
6
Adenovirus encoding the thyrotropin receptor A-subunit improves the efficacy of dendritic cell-induced Graves' hyperthyroidism in mice.编码促甲状腺激素受体A亚基的腺病毒可提高树突状细胞诱导的小鼠格雷夫斯甲亢的疗效。
J Autoimmun. 2006 Feb;26(1):32-6. doi: 10.1016/j.jaut.2005.08.008. Epub 2005 Oct 18.
7
Adenovirus-mediated gene delivery of interleukin-10, but not transforming growth factor beta, ameliorates the induction of Graves' hyperthyroidism in BALB/c mice.腺病毒介导的白细胞介素-10而非转化生长因子β的基因递送可改善BALB/c小鼠中格雷夫斯甲状腺功能亢进症的诱导。
Clin Exp Immunol. 2005 Sep;141(3):405-11. doi: 10.1111/j.1365-2249.2005.02874.x.
8
Signal transducer and activator of transcription (Stat)-6-dependent, but not Stat4-dependent, immunity is required for the development of autoimmunity in Graves' hyperthyroidism.信号转导及转录激活因子(Stat)-6依赖性而非Stat4依赖性免疫对于格雷夫斯氏甲状腺功能亢进症自身免疫的发展是必需的。
Endocrinology. 2004 Aug;145(8):3724-30. doi: 10.1210/en.2004-0352. Epub 2004 Apr 29.
9
Interleukin 10 deficiency attenuates induction of anti-TSH receptor antibodies and hyperthyroidism in a mouse Graves' model.白细胞介素 10 缺乏可减弱小鼠格雷夫斯病模型中抗促甲状腺激素受体抗体的产生和甲状腺功能亢进。
J Endocrinol. 2011 Jun;209(3):353-7. doi: 10.1530/JOE-11-0129. Epub 2011 Apr 7.
10
Immune deviation away from Th1 in interferon-gamma knockout mice does not enhance TSH receptor antibody production after naked DNA vaccination.在干扰素-γ基因敲除小鼠中,免疫反应偏离Th1型并不会增强裸DNA疫苗接种后的促甲状腺激素受体抗体产生。
Endocrinology. 2002 Apr;143(4):1182-9. doi: 10.1210/endo.143.4.8745.

引用本文的文献

1
RNA aptamers with specific binding affinity to CD40 (CD40Apt) represents a promising antagonist of the CD40-CD40L signaling for thyroid-associated ophthalmopathy (TAO) treatment in mouse.RNA 适体与 CD40(CD40Apt)具有特异性结合亲和力,代表了一种有前途的 CD40-CD40L 信号通路拮抗剂,可用于治疗甲状腺相关眼病(TAO)的小鼠模型。
J Transl Med. 2023 Jun 18;21(1):396. doi: 10.1186/s12967-023-04217-0.
2
A transgenic mouse that spontaneously develops pathogenic TSH receptor antibodies will facilitate study of antigen-specific immunotherapy for human Graves' disease.一种自发产生致病性 TSH 受体抗体的转基因小鼠将有助于研究针对人类格雷夫斯病的抗原特异性免疫疗法。
Endocrine. 2019 Nov;66(2):137-148. doi: 10.1007/s12020-019-02083-9. Epub 2019 Sep 27.
3
Helminths protect against type 1 diabetes: effects and mechanisms.蠕虫可预防1型糖尿病:作用及机制
Parasitol Res. 2019 Apr;118(4):1087-1094. doi: 10.1007/s00436-019-06247-4. Epub 2019 Feb 13.
4
Evidence that TSH Receptor A-Subunit Multimers, Not Monomers, Drive Antibody Affinity Maturation in Graves' Disease.促甲状腺激素受体A亚基多聚体而非单体驱动格雷夫斯病抗体亲和力成熟的证据。
J Clin Endocrinol Metab. 2015 Jun;100(6):E871-5. doi: 10.1210/jc.2015-1528. Epub 2015 Apr 9.
5
Diosgenin relieves goiter via the inhibition of thyrocyte proliferation in a mouse model of Graves' disease.薯蓣皂苷元通过抑制 Graves 病小鼠模型甲状腺细胞增殖缓解甲状腺肿。
Acta Pharmacol Sin. 2014 Jan;35(1):65-73. doi: 10.1038/aps.2013.133. Epub 2013 Nov 18.
6
Breaking tolerance to thyroid antigens: changing concepts in thyroid autoimmunity.打破对甲状腺抗原的耐受性:甲状腺自身免疫中概念的改变。
Endocr Rev. 2014 Feb;35(1):59-105. doi: 10.1210/er.2013-1055. Epub 2013 Dec 4.
7
Role of cytokines in the pathogenesis and suppression of thyroid autoimmunity.细胞因子在甲状腺自身免疫发病机制和抑制中的作用。
J Interferon Cytokine Res. 2011 Oct;31(10):721-31. doi: 10.1089/jir.2011.0049. Epub 2011 Aug 8.
8
B cell-targeted therapy with anti-CD20 monoclonal antibody in a mouse model of Graves' hyperthyroidism.在 Graves 甲亢的小鼠模型中,用抗 CD20 单克隆抗体进行 B 细胞靶向治疗。
Clin Exp Immunol. 2011 Mar;163(3):309-17. doi: 10.1111/j.1365-2249.2010.04301.x. Epub 2011 Jan 14.
9
Infections and autoimmunity: a panorama.感染与自身免疫:全景概览
Clin Rev Allergy Immunol. 2008 Jun;34(3):283-99. doi: 10.1007/s12016-007-8048-8.

本文引用的文献

1
Schistosoma mansoni and alpha-galactosylceramide: prophylactic effect of Th1 Immune suppression in a mouse model of Graves' hyperthyroidism.曼氏血吸虫与α-半乳糖神经酰胺:Th1免疫抑制在Graves病甲亢小鼠模型中的预防作用
J Immunol. 2004 Aug 1;173(3):2167-73. doi: 10.4049/jimmunol.173.3.2167.
2
Induction of hyperthyroidism in mice by intradermal immunization with DNA encoding the thyrotropin receptor.通过皮内免疫接种编码促甲状腺激素受体的DNA诱导小鼠甲状腺功能亢进。
Clin Exp Immunol. 2004 Jun;136(3):413-22. doi: 10.1111/j.1365-2249.2004.02483.x.
3
Signal transducer and activator of transcription (Stat)-6-dependent, but not Stat4-dependent, immunity is required for the development of autoimmunity in Graves' hyperthyroidism.信号转导及转录激活因子(Stat)-6依赖性而非Stat4依赖性免疫对于格雷夫斯氏甲状腺功能亢进症自身免疫的发展是必需的。
Endocrinology. 2004 Aug;145(8):3724-30. doi: 10.1210/en.2004-0352. Epub 2004 Apr 29.
4
The thyrotropin receptor autoantigen in Graves disease is the culprit as well as the victim.格雷夫斯病中的促甲状腺激素受体自身抗原既是罪魁祸首,也是受害者。
J Clin Invest. 2003 Jun;111(12):1897-904. doi: 10.1172/JCI17069.
5
A major role for non-major histocompatibility complex genes but not for microorganisms in a novel murine model of Graves' hyperthyroidism.在一种新型的格雷夫斯氏甲状腺功能亢进小鼠模型中,非主要组织相容性复合体基因起主要作用,而微生物不起主要作用。
Thyroid. 2003 Mar;13(3):233-8. doi: 10.1089/105072503321582024.
6
Prevention of autoantibody-mediated Graves'-like hyperthyroidism in mice with IL-4, a Th2 cytokine.用白细胞介素-4(一种Th2细胞因子)预防小鼠自身抗体介导的格雷夫斯样甲状腺功能亢进症。
J Immunol. 2003 Apr 1;170(7):3522-7. doi: 10.4049/jimmunol.170.7.3522.
7
Absence of IL-4, and not suppression of the Th2 response, prevents development of experimental autoimmune Graves' disease.缺乏白细胞介素-4而非抑制辅助性T细胞2型(Th2)反应可阻止实验性自身免疫性格雷夫斯病的发展。
J Immunol. 2003 Feb 15;170(4):2195-204. doi: 10.4049/jimmunol.170.4.2195.
8
Absence of IL-4 facilitates the development of chronic autoimmune myasthenia gravis in C57BL/6 mice.白细胞介素-4的缺失促进了C57BL/6小鼠慢性自身免疫性重症肌无力的发展。
J Immunol. 2003 Jan 1;170(1):604-12. doi: 10.4049/jimmunol.170.1.604.
9
Serum antibody response and nasal lymphoid tissue (NALT) structure in the absence of IL-4 or IFN-gamma.在缺乏白细胞介素-4或干扰素-γ的情况下血清抗体反应及鼻淋巴组织(NALT)结构
Cytokine. 2002 Nov 7;20(3):107-12. doi: 10.1006/cyto.2002.1980.
10
Is 'timing' important for cytokine polarization?细胞因子极化的“时机”重要吗?
Trends Immunol. 2002 May;23(5):246-9. doi: 10.1016/s1471-4906(02)02200-7.

促甲状腺激素受体腺病毒诱导的格雷夫斯甲亢在干扰素-γ和白细胞介素-4基因敲除小鼠中均有所减轻;对Th1/Th2模式的启示。

TSH receptor-adenovirus-induced Graves' hyperthyroidism is attenuated in both interferon-gamma and interleukin-4 knockout mice; implications for the Th1/Th2 paradigm.

作者信息

Nagayama Y, Saitoh O, McLachlan S M, Rapoport B, Kano H, Kumazawa Y

机构信息

Department of Medical Gene Technology, Atomic Bomb Disease Institute, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan.

出版信息

Clin Exp Immunol. 2004 Dec;138(3):417-22. doi: 10.1111/j.1365-2249.2004.02641.x.

DOI:10.1111/j.1365-2249.2004.02641.x
PMID:15544617
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1809247/
Abstract

The role of the Th1/Th2 balance in the pathogenesis of murine Graves' hyperthyroidism is controversial. In BALB/c mice injected with adenovirus expressing TSH receptor (TSHR-adeno model), we found that suppression of TSHR-specific Th1 immune responses by exogenous interleukin-4 (IL-4), alpha-galactosylceramide or helminth (Schistosoma mansoni) infection was associated with inhibition of hyperthyroidism, indicating the critical role for Th1 cytokines. In contrast, BALB/c IL-4 knockout (KO), but not interferon-gamma (IFN-gamma) KO mice failed to develop Graves' hyperthyroidism when injected with TSHR-expressing M12 B lymphoma cells (TSHR-M12 model), suggesting the importance of Th2 cytokine IL-4. To reconcile differences in these two models, we used IL-4 KO and IFN-gamma KO BALB/c mice in the TSHR-adeno model. Unlike wild-type (wt) BALB/c mice in which 60% developed hyperthyroidism, only 13 and 7% of IL-4 KO and IFN-gamma KO mice, respectively, became hyperthyroid. Thyroid stimulating antibodies were positive in most hyperthyroid mice. TSHR antibody titres determined by TSH binding inhibition and ELISA were comparable in all three groups. IgG1 and IgG2a TSHR antibody titres were similar in IFN-gamma KO and wt mice, whereas IgG1 TSHR antibody titres and TSHR-specific splenocyte IFN-gamma secretion were lower in IL-4 KO than in IFN-gamma KO and wt mice, respectively. Our results clearly implicate both IFN-gamma and IL-4 in development of hyperthyroidism in the TSHR-adeno model. These data, together with the previous report, also indicate different cytokine requirements in these two Graves' models, with IFN-gamma being more important in the TSHR-adeno than the TSHR-M12 model. Moreover, our previous and present observations indicate a difference in the role of exogenous versus endogenous IL-4 in TSHR-adenovirus induced Graves' hyperthyroidism.

摘要

Th1/Th2平衡在小鼠格雷夫斯氏甲状腺功能亢进症发病机制中的作用存在争议。在注射表达促甲状腺激素受体的腺病毒的BALB/c小鼠(TSHR-腺病毒模型)中,我们发现外源性白细胞介素-4(IL-4)、α-半乳糖神经酰胺或蠕虫(曼氏血吸虫)感染对TSHR特异性Th1免疫反应的抑制与甲状腺功能亢进的抑制相关,这表明Th1细胞因子起关键作用。相反,当注射表达TSHR的M12 B淋巴瘤细胞时(TSHR-M12模型),BALB/c IL-4基因敲除(KO)小鼠而非干扰素-γ(IFN-γ)基因敲除小鼠未能发生格雷夫斯氏甲状腺功能亢进症,这表明Th2细胞因子IL-4的重要性。为了协调这两种模型中的差异,我们在TSHR-腺病毒模型中使用了IL-4基因敲除和IFN-γ基因敲除的BALB/c小鼠。与60%发生甲状腺功能亢进的野生型(wt)BALB/c小鼠不同,IL-4基因敲除小鼠和IFN-γ基因敲除小鼠分别只有13%和7%出现甲状腺功能亢进。大多数甲状腺功能亢进小鼠的促甲状腺激素刺激抗体呈阳性。通过促甲状腺激素结合抑制和酶联免疫吸附测定法测定的TSHR抗体滴度在所有三组中相当。IFN-γ基因敲除小鼠和野生型小鼠的IgG1和IgG2a TSHR抗体滴度相似,而IL-4基因敲除小鼠的IgG1 TSHR抗体滴度和TSHR特异性脾细胞IFN-γ分泌分别低于IFN-γ基因敲除小鼠和野生型小鼠。我们的结果清楚地表明,在TSHR-腺病毒模型中,IFN-γ和IL-4均参与甲状腺功能亢进的发生。这些数据与之前的报告一起还表明,在这两种格雷夫斯氏模型中细胞因子需求不同,在TSHR-腺病毒模型中IFN-γ比在TSHR-M12模型中更重要。此外,我们之前和现在的观察结果表明,外源性与内源性IL-4在TSHR-腺病毒诱导的格雷夫斯氏甲状腺功能亢进症中的作用存在差异。